DrugPatentWatch Database Preview
Belcher Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for BELCHER, and when can generic versions of BELCHER drugs launch?
BELCHER has seventeen approved drugs.
There are three US patents protecting BELCHER drugs.
Summary for Belcher
| US Patents: | 3 |
| Tradenames: | 13 |
| Ingredients: | 13 |
| NDAs: | 17 |
| Patent Litigation for Belcher: | See patent lawsuits for Belcher |
Drugs and US Patents for Belcher
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Belcher Pharms | AMOXICILLIN | amoxicillin | CAPSULE;ORAL | 062058-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Belcher | CEFIXIME | cefixime | FOR SUSPENSION;ORAL | 206938-001 | Feb 6, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Belcher | TACROLIMUS | tacrolimus | CAPSULE;ORAL | 206651-001 | Nov 30, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Belcher | EPINEPHRINE | epinephrine | SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | 205029-001 | Jul 29, 2014 | RX | Yes | Yes | 10,039,728 | Start Trial | Start Trial | ||||
| Belcher | POTASSIUM CHLORIDE | potassium chloride | FOR SOLUTION;ORAL | 212183-001 | May 6, 2019 | AA | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
